Clinical exome-based panel testing for medically actionable secondary findings in a cohort of 383 Italian participants

Clinical exome-based panel testing for medically actionable secondary findings in a cohort of 383 Italian participants

Background: Next-generation sequencing-based genetic testing represents a great opportunity to identify hereditary predispositions to specific pathological conditions and to promptly implement health surveillance or therapeutic protocols in case of disease. The term secondary finding refers to the a...

Olles dieđut

Bibliográfalaš dieđut
Váldodahkkit: Stefania Martone, Autilia Tommasina Buonagura, Roberta Marra, Barbara Eleni Rosato, Federica Del Giudice, Ferdinando Bonfiglio, Mario Capasso, Achille Iolascon, Immacolata Andolfo, Roberta Russo
Materiálatiipa: Artihkal
Giella:English
Almmustuhtton: Frontiers Media S.A. 2022-11-01
Ráidu:Frontiers in Genetics
Fáttát:
secondary findings
clinical exome
genetic testing
ACMG actionable genes
NGS testing
Liŋkkat:https://www.frontiersin.org/articles/10.3389/fgene.2022.956723/full

Interneahtta

https://www.frontiersin.org/articles/10.3389/fgene.2022.956723/full

Geahča maid